MetaCap

Corbus Pharmaceuticals Insider Trades

NASDAQ: CRBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.38+0.11 (+2.09%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
3 · $126.25K
Sales
17 · $1.69M
Shares bought / sold
16.10K / 143.16K
Net activity
Net selling $1.6 million

Corbus Pharmaceuticals insider activity

Over the last 12 months, Corbus Pharmaceuticals insiders reported 36 transactions on SEC Form 4: 3 open-market purchases and 17 sales. Insiders bought $126,255 and sold $1.7 million worth of stock, for net insider selling of $1.6 million. The largest seller was Cohen Yuval, with $750,552 in reported sales.

The most recent filing shows Ben Yong (Director) selling 2,000 shares at $7.84 on Sep 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CRBP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CRBP insider transactions

Corbus Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Sep 14, 2026Ben YongDirectorSale2,000$15.68KForm 4
Aug 16, 2026Nicacio Leonardo VianaChief Medical OfficerAward58,333—Form 4
Aug 11, 2026Saxena Nishant CChief Business OfficerBuy2,600$25.04KForm 4
Aug 7, 2026Moran Sean F.Chief Financial OfficerSale12,000$120.97KForm 4
Aug 7, 2026Cohen YuvalChief Executive OfficerSale17,000$171.40KForm 4
Jun 10, 2026Altmeyer AnneDirectorSale2,412$19.09KForm 4
Jun 10, 2026Jenkins John KennethDirectorSale4,800$37.99KForm 4
Jun 10, 2026Kung WinstonDirectorSale2,026$16.03KForm 4
Jun 3, 2026Saxena Nishant CChief Business OfficerBuy9,000$68.22KForm 4
Jun 2, 2026Saxena Nishant CChief Business OfficerBuy4,500$33.00KForm 4
May 21, 2026Saxena Nishant CChief Business OfficerAward58,300—Form 4
May 19, 2026Altmeyer AnneDirectorAward3,800—Form 4
May 19, 2026Pfeiffenberger BrentDirectorAward7,500—Form 4
May 19, 2026Ben YongDirectorAward3,800—Form 4
May 19, 2026Kung WinstonDirectorAward3,800—Form 4
May 19, 2026Jenkins John KennethDirectorAward3,800—Form 4
May 19, 2026Jacques Rachelle SuzanneDirectorAward3,800—Form 4
Mar 2, 2026Smethurst DominicChief Medical OfficerSale6,097$50.60KForm 4
Feb 17, 2026Hodgson IanChief Operating OfficerSale847$6.25KForm 4
Feb 13, 2026Moran Sean F.Chief Financial OfficerSale4,701$36.59KForm 4
Feb 13, 2026Cohen YuvalChief Executive OfficerSale13,871$107.95KForm 4
Feb 3, 2026Hodgson IanChief Operating OfficerSale2,415$19.54KForm 4
Feb 3, 2026Smethurst DominicChief Medical OfficerSale3,285$26.57KForm 4
Jan 14, 2026Hodgson IanChief Operating OfficerAward28,365—Form 4
Jan 14, 2026Moran Sean F.Chief Financial OfficerAward28,082—Form 4
Jan 14, 2026Cohen YuvalChief Executive OfficerAward50,000—Form 4
Jan 14, 2026Smethurst DominicChief Medical OfficerAward28,365—Form 4
Dec 11, 2025Cormorant Asset Management, LP & Cormorant Global Healthcare Master Fund, LP & Chen Bihua10% OwnerSale30,029$344.01KForm 4
Oct 27, 2025Cohen YuvalChief Executive OfficerSale8,973$153.80KForm 4
Oct 27, 2025Cohen YuvalChief Executive OfficerOption exercise8,973$38.22KForm 4
Oct 24, 2025Cohen YuvalChief Executive OfficerSale18,660$317.41KForm 4
Oct 24, 2025Cohen YuvalChief Executive OfficerOption exercise18,660$79.49KForm 4
Oct 24, 2025Moran Sean F.Chief Financial OfficerSale12,981$220.94KForm 4
Oct 24, 2025Moran Sean F.Chief Financial OfficerOption exercise12,981$55.30KForm 4
Oct 20, 2025Altmeyer AnneDirectorSale1,060$21.73KForm 4
Oct 20, 2025Altmeyer AnneDirectorOption exercise1,060$5.09KForm 4
May 30, 2025Jacques Rachelle SuzanneDirectorAward4,800—Form 4
May 30, 2025HOLMER ALAN FDirectorAward4,800—Form 4
May 30, 2025Altmeyer AnneDirectorAward4,800—Form 4
May 30, 2025Altmeyer AnneDirectorSale1,392$10.10KForm 4
May 30, 2025Ben YongDirectorAward4,800—Form 4
May 30, 2025Jenkins John KennethDirectorAward4,800—Form 4
May 30, 2025Jenkins John KennethDirectorSale2,783$20.47KForm 4
May 30, 2025Kung WinstonDirectorAward4,800—Form 4
Mar 6, 2025Smethurst DominicChief Medical OfficerSale6,393$43.33KForm 4
Feb 14, 2025Cohen YuvalChief Executive OfficerSale7,134$62.46KForm 4
Feb 14, 2025Moran Sean F.Chief Financial OfficerSale2,792$24.45KForm 4
Jan 31, 2025Smethurst DominicChief Medical OfficerAward27,200—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related